Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome

Vlatka Zoldoš, Tomislav Horvat, Mislav Novokmet, Cyrille Cuenin, Ana Mužinić, Maja Pučić, Jennifer E Huffman, Olga Gornik, Ozren Polašek, Harry Campbell, Caroline Hayward, Alan F Wright, Igor Rudan, Katharine Owen, Mark I McCarthy, Zdenko Herceg, Gordan Lauc

Research output: Contribution to journalArticlepeer-review


Protein glycosylation is a ubiquitous modification that affects the structure and function of proteins. Our recent genome wide association study identified transcription factor HNF1A as an important regulator of plasma protein glycosylation. To evaluate the potential impact of epigenetic regulation of HNF1A on protein glycosylation we analyzed CpG methylation in 810 individuals. The association between methylation of four CpG sites and the composition of plasma and IgG glycomes was analyzed. Several statistically significant associations were observed between HNF1A methylation and plasma glycans, while there were no significant associations with IgG glycans. The most consistent association with HNF1A methylation was observed with the increase in the proportion of highly branched glycans in the plasma N-glycome. The hypothesis that inactivation of HNF1A promotes branching of glycans was supported by the analysis of plasma N-glycomes in 61 patients with inactivating mutations in HNF1A, where the increase in plasma glycan branching was also observed. This study represents the first demonstration of epigenetic regulation of plasma glycome composition, suggesting a potential mechanism by which epigenetic deregulation of the glycome may contribute to disease development.
Original languageEnglish
Pages (from-to)164-72
Number of pages9
Issue number2
Publication statusPublished - 2012


Dive into the research topics of 'Epigenetic silencing of HNF1A associates with changes in the composition of the human plasma N-glycome'. Together they form a unique fingerprint.

Cite this